UHER, Michal, Lenka PUCZOKOVÁ, Karel HEJDUK, Jaroslav KOČA, Jiřina MERTOVÁ, Daniel KLIMEŠ, Jiří VENCOVSKÝ, Karel PAVELKA, Karel HORÁK, Jakub ZÁVADA and Ladislav DUŠEK. Léčba revmatoidní artritidy infliximabem (Remicade®) v České republice: Základní přehled a hodnocení účinnosti a bezpečnosti léčby z dat registru ATTRA (Treatment of rheumatoid arthritis in the Czech Republic with infliximabem (Remicade®): General overview and evaluation of efectiveness and safety on data from the ATTRA registry). Brno: Masarykova univerzita, 2014, 31 pp.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Léčba revmatoidní artritidy infliximabem (Remicade®) v České republice: Základní přehled a hodnocení účinnosti a bezpečnosti léčby z dat registru ATTRA
Name (in English) Treatment of rheumatoid arthritis in the Czech Republic with infliximabem (Remicade®): General overview and evaluation of efectiveness and safety on data from the ATTRA registry
Authors UHER, Michal (203 Czech Republic, belonging to the institution), Lenka PUCZOKOVÁ (203 Czech Republic, belonging to the institution), Karel HEJDUK (203 Czech Republic, belonging to the institution), Jaroslav KOČA (203 Czech Republic, belonging to the institution), Jiřina MERTOVÁ (203 Czech Republic, belonging to the institution), Daniel KLIMEŠ (203 Czech Republic, belonging to the institution), Jiří VENCOVSKÝ (203 Czech Republic), Karel PAVELKA (203 Czech Republic), Karel HORÁK (203 Czech Republic), Jakub ZÁVADA (203 Czech Republic) and Ladislav DUŠEK (203 Czech Republic, guarantor, belonging to the institution).
Edition Brno, 31 pp. 2014.
Publisher Masarykova univerzita
Other information
Original language Czech
Type of outcome Research report
Field of Study 30200 3.2 Clinical medicine
Country of publisher Czech Republic
Confidentiality degree is not subject to a state or trade secret
RIV identification code RIV/00216224:14710/14:00080262
Organization unit Institute of Biostatistics and Analyses
Keywords in English rheumatoid arthritis; treatment; clinical database; registry
Changed by Changed by: Mgr. Jakub Gregor, Ph.D., učo 16577. Changed: 19/6/2015 13:28.
Abstract
Zpráva prezentuje analýzu akutálních dat klinického registru ATTRA a hodnotí účinnost a bezpečnost léčby revmatoidní artritidy infliximabem v České republice.
Abstract (in English)
The report presents analysis of recent data from the ATTRA clinical registry, including assessment of effectiveness and safety of the rheumatoid arthritis treatment with infliximab in the Czech Republic.
PrintDisplayed: 6/10/2024 14:32